"This institute model will lower barriers for access to some of the highest quality care in the world,” says Alexander Kutikov, MD, FACS.
Fox Chase Cancer Center and Temple Health have announced plans to implement the new Fox Chase-Temple Urologic Institute to treat patients with both benign and oncologic conditions.1
President and CEO of Fox Chase Cancer Center, Robert Uzzo, MD, MBA, FACS, will serve as the director of the Institute. The executive management team consists of Alexander Kutikov, MD, FACS, Jack Mydlo, MD, MBA, Daniel Eun, MD, and Jay Simhan, MD, FACS.
“One of the primary goals of the Institute is to extend our expertise across all populations in Philadelphia—in the region and beyond—to make sure that both well-represented and underrepresented communities get access to integrated, innovative, patient centered, comprehensive specialty specific care. This institute model will lower barriers for access to some of the highest quality care in the world,” said Kutikov in an interview with Urology Times®. Kutikov is the chair in the department of urology at Fox Chase Cancer Center and a professor of urology at Temple University.
The Institute seeks to integrate 3 groups of providers into 1 holistic system. These include the group at Fox Chase Cancer Center, the group at Temple University Hospital, and a new group of benign fellowship-trained urologists that manage a variety of simple and complex urinary conditions.
The model for the Institute, the group emphasized, is based off a horizontal approach to care, where the physicians work alongside one another and operate in a patient-focused manner rather than in the traditional vertical model seen in other organizations, which is more provider-focused.
“The question that was before us was how do we integrate these 3 outstanding groups that have evolved along different lines, [into] a single entity, and organize it in such a way that it is driven by delivering outcomes most important to patients? The concept is that when any patient calls or enters any door in our institute, they get the same outstanding care from a group of providers who collaborate and integrate care across a big organization that sees 1000s of patients and has specialists that are very focused on singular diseases. Our core mission is to improve the lives that seek our help.The Fox Chase – Temple Urologic Institute will be that resource, that partner in your care.” explained Uzzo.
The different sites of the Institute will span across Philadelphia and the surrounding area, including 8 outpatient offices in Buckingham, East Norriton, Center City, Fort Washington, Huntington Pike, Chestnut Hill Hospital, Temple Health – Suburban, and the main campus of Temple University Hospital, as well as 2 inpatient offices at the main campus of Fox Chase Cancer Center and the Temple University Hospital – Jeanes Campus. The Institute will include over 20 urologists and dozens of additional providers, nurses, researchers, and allied faculty.
“We're bringing together a group of very mature and experienced providers. These are well-oiled teams that are coming together to work seamlessly, integrate care, transition patients without any barriers from their cancer care to their benign urologic care or conversely for those with benign condition who develop urinary cancers.We will extend our holistic care model that is less achievable in departmental vertical models,” concluded Mydlo. Mydlo is the chair in the department of urology and a professor of urology at the Lewis Katz School of Medicine at Temple University.
1. Temple Health launches new Fox Chase-Temple Urologic Institute. News release. Fox Chase Cancer Center. April 27. 2023. Accessed May 11, 2023. https://www.foxchase.org/news/2023-04-27-temple-health-launches-new-fox-chase-temple-urologic-institute